| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Executive Chairman +1 more
4 companies
Kirk Randal J is a Director, 10% Owner at PRECIGEN, INC. with holdings across 4 companies. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $487.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2015 | PGEN Precigen, Inc. | Chief Executive Officer | Buy | 237,525 | $30.69 | $7,289,642.25 | +3.8% | |
| Sep 2, 2015 | PGEN Precigen, Inc. | 10% Owner | Buy | 937,500 | $3.20 | $3,000,000.00 | +10.8% | |
| Jul 27, 2015 | PGEN Precigen, Inc. | 10% Owner | Buy | 975,987 | $5.80 | $5,660,724.60 | +16.2% | |
| Mar 16, 2015 | PGEN Precigen, Inc. | 10% Owner | Buy | 13,939,392 | $0.17 | $2,299,999.68 | +58.1% | |
| Feb 9, 2015 | TCRT Alaunos Therapeutics, Inc. | Director, 10% Owner | Buy | 1,440,000 | $8.75 | $12,600,000.00 | +8.8% |